Avril Biopharma Inc

Avril Biopharma, Inc. uses the latest biotechnologies to design, test and manufacture medicines on demand. We address the need for rapid development and production of vaccines, therapeutic and diagnostic products at affordable cost. Our opportunities are in two arenas –Global Health and Personalized Medicine.  We have carefully chosen AI, genomics and synthetic biotechnologies to give every patient access to the promise of gene therapy, targeted anti-cancer therapies and many other chronic and infectious disease treatments –at an affordable price.

At present we are seeking immediate funding and collaborations to manufacture diagnostic, vaccine and therapeutic anti-COVID-19 products with our unique egg-based platform called AdCEV™.  With this technology, a hen egg can be used to make life-saving vaccines or the much-needed components for antibody testing. We could also make a wide range of high-value biosimilar products like insulin, erythropoeitin, interferon, and many others.

With our revolutionary genomics and bioinformatics platform, we can analyse the codes of emerging viruses like SARS-COV-2 so that more targeted vaccines and more reliable tests can be made to suit regional populations. We have already successfully made prototypes for rabies and influenza subunit vaccines and we are looking for partners to develop COVID-19 vaccines.

In the future, drugs will no longer be one-size-fits-all. Biopharmaceutical, nutraceutical and cosmeceutical products will all be personalized and made to treat each individual. Avril Biopharma is making that future possible for everyone.